giovedì 16 aprile 2015

Edoardo Cignoli : Bristol-Myers to Sell Cancer Drug Rights to Eli Lilly

Bristol-Myers Squibb said that it agreed to transfer North America commercialization rights to its cancer drug Erbitux to Eli Lilly.



via WSJ.com: US Business http://ift.tt/1FOVjuD

Nessun commento:

Posta un commento